$BFYW
Better For You Wellness, Inc.

2023 Q1 Form 10-Q Financial Statement

#000121390023017302 Filed on March 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $2.410K $6.986K $1.520K
YoY Change 58.55%
Cost Of Revenue $3.030K $5.823K $730.00
YoY Change 315.07%
Gross Profit -$620.00 $1.163K $790.00
YoY Change -178.48%
Gross Profit Margin -25.73% 16.65% 51.97%
Selling, General & Admin $1.151M $258.4K $546.9K
YoY Change 110.53% -75.76%
% of Gross Profit 22218.49% 69226.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $200.00 $190.00
YoY Change
% of Gross Profit 16.34%
Operating Expenses $1.151M $605.2K $482.0K
YoY Change 138.89% -43.24%
Operating Profit -$1.152M -$604.0K -$481.2K
YoY Change 139.41% -43.34%
Interest Expense -$55.94K -$55.94K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$55.94K
YoY Change
Pretax Income -$1.208M -$659.9K -$481.2K
YoY Change 151.03% -38.1%
Income Tax
% Of Pretax Income
Net Earnings -$1.208M -$659.9K -$481.2K
YoY Change 151.03% -38.1% 9650.56%
Net Earnings / Revenue -50121.99% -9446.55% -31657.24%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 -$1.448K
COMMON SHARES
Basic Shares Outstanding 404.0M shares 390.0M shares
Diluted Shares Outstanding 372.0M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.77K $3.150K $9.640K
YoY Change 42.84%
Cash & Equivalents $13.77K $3.154K $9.719K
Short-Term Investments
Other Short-Term Assets $18.49K $101.5K
YoY Change
Inventory $979.00 $1.657K $13.11K
Prepaid Expenses $18.49K $23.43K
Receivables $1.460K $1.495K
Other Receivables $0.00 $108.3K
Total Short-Term Assets $34.71K $216.1K $9.640K
YoY Change 260.01%
LONG-TERM ASSETS
Property, Plant & Equipment $1.547K $1.741K $730.00
YoY Change 111.92%
Goodwill $583.5K $583.5K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $585.0K $585.2K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $34.71K $216.1K $9.640K
Total Long-Term Assets $585.0K $585.2K $0.00
Total Assets $619.7K $801.3K $9.640K
YoY Change 6328.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $390.8K $311.5K $345.4K
YoY Change 13.15%
Accrued Expenses $0.00 $172.9K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $887.8K $202.0K $202.5K
YoY Change 338.46% 28.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.719M $799.5K $375.4K
YoY Change 357.99% 192.03%
LONG-TERM LIABILITIES
Long-Term Debt $2.220K $601.5K $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $2.224K $601.5K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.719M $799.5K $375.4K
Total Long-Term Liabilities $2.224K $601.5K $0.00
Total Liabilities $1.722M $1.401M $375.4K
YoY Change 358.59% 411.73%
SHAREHOLDERS EQUITY
Retained Earnings -$6.076M -$3.958M -$1.748M
YoY Change 247.49% 117.78%
Common Stock $40.40K $39.00K $37.08K
YoY Change 8.98% 7.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.102M -$599.6K -$365.8K
YoY Change
Total Liabilities & Shareholders Equity $619.7K $801.3K $9.640K
YoY Change 6328.8%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$1.208M -$659.9K -$481.2K
YoY Change 151.03% -38.1% 9650.56%
Depreciation, Depletion And Amortization $200.00 $190.00
YoY Change
Cash From Operating Activities -$56.80K -$126.0K -$144.3K
YoY Change -60.64% -19.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$6.090K -$2.320K
YoY Change
Cash From Investing Activities -$6.090K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $68.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 73.50K 127.0K 154.0K
YoY Change -52.26% -18.79%
NET CHANGE
Cash From Operating Activities -56.80K -126.0K -144.3K
Cash From Investing Activities -6.090K 0.000
Cash From Financing Activities 73.50K 127.0K 154.0K
Net Change In Cash 10.61K 1.030K 9.640K
YoY Change 10.06%
FREE CASH FLOW
Cash From Operating Activities -$56.80K -$126.0K -$144.3K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$56.80K -$126.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56262
dei Entity Registrant Name
EntityRegistrantName
BETTER FOR YOU WELLNESS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2903933
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
375408 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
284499 usd
CY2022Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
895 usd
CY2022Q4 bfyw Revenue Payable
RevenuePayable
128 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
1349 East Broad Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43205
dei City Area Code
CityAreaCode
1 (614)
dei Local Phone Number
LocalPhoneNumber
368-9898
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
404014987 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3154 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9642 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1495 usd
CY2022Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
108301 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23425 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1657 usd
CY2022Q4 us-gaap Deferred Fuel Cost
DeferredFuelCost
78072 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
216104 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
9642 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1741 usd
CY2022Q4 us-gaap Goodwill
Goodwill
583484 usd
CY2022Q4 us-gaap Assets
Assets
801329 usd
CY2022Q1 us-gaap Assets
Assets
9642 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
311541 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
414 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
202000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
799478 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
375408 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
2216 usd
CY2022Q4 bfyw Notes Payable Shopifys Capital
NotesPayableShopifysCapital
166 usd
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
599111 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1400970 usd
CY2022Q1 us-gaap Liabilities
Liabilities
375408 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
700000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
700000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
700000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
700000 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
70 usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
70 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
389995988 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
389995988 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
370747042 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
370747042 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
39001 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
37075 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3319048 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1485364 usd
CY2022Q1 bfyw Shares Cancelable
SharesCancelable
-250000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3957760 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1638275 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-599641 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-365766 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
801329 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9642 usd
CY2022Q4 us-gaap Revenues
Revenues
6986 usd
us-gaap Revenues
Revenues
9008 usd
CY2022Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5823 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15381 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
1163 usd
us-gaap Gross Profit
GrossProfit
-6373 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
346762 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
532243 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1332475 usd
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
609243 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
258401 usd
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
533854 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
852184 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
542910 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
605163 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
1066097 usd
us-gaap Operating Expenses
OperatingExpenses
2184659 usd
us-gaap Operating Expenses
OperatingExpenses
1152153 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-604000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1066097 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2191032 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1152153 usd
CY2022Q4 us-gaap Interest Expense Other
InterestExpenseOther
55935 usd
us-gaap Interest Expense Other
InterestExpenseOther
128453 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55935 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-128453 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-659936 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1066097 usd
us-gaap Net Income Loss
NetIncomeLoss
-2319485 usd
us-gaap Net Income Loss
NetIncomeLoss
-1152153 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372031446 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
361664351 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
372031446 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
287241405 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-365766 usd
CY2022Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
272735 usd
CY2022Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
550000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
411315 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
78072 usd
CY2022Q2 bfyw Stockissuanceofwarrants Warrant Issuance
StockissuanceofwarrantsWarrantIssuance
13514 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
49686 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-891872 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
117684 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
250698 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
3750 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
274025 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Mark To Market
AdjustmentsToAdditionalPaidInCapitalMarkToMarket
17188 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-223060 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-767677 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-327392 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31950 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
274025 usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
64211 usd
CY2022Q4 bfyw Common Shares Issued For Debt Settlement For Purchase Of Subsititary No Subsidiary Acquired This
CommonSharesIssuedForDebtSettlementForPurchaseOfSubsititaryNoSubsidiaryAcquiredThis
17500 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-659936 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-599641 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1185 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-4935 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-3750 usd
CY2021Q2 bfyw Preferred Shares Issued After Reorganization
PreferredSharesIssuedAfterReorganization
70000 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3951 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-72051 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1850 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7000 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2990 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14005 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5865 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
532243 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
265946 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-1066097 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-273773 usd
us-gaap Net Income Loss
NetIncomeLoss
-2319485 usd
us-gaap Net Income Loss
NetIncomeLoss
-1152153 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1332475 usd
us-gaap Share Based Compensation
ShareBasedCompensation
875189 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
86810 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
582 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1495 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
108301 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
23588 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-11440 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-63866 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
113267 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
41643 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
284499 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1675 usd
us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
156756 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-760961 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6941 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
2323 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2323 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
56640 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
558000 usd
us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
202000 usd
bfyw Common Stock Issuance Acquisition
CommonStockIssuanceAcquisition
3750 usd
bfyw Expenses Contributed To Capital
ExpensesContributedToCapital
49686 usd
bfyw Expenses Contributed To Capital
ExpensesContributedToCapital
6941 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
756796 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6941 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6488 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9642 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3154 usd
bfyw Common Shares Issued For Notes Payable Extention
CommonSharesIssuedForNotesPayableExtention
30702 usd
us-gaap Stock Issued1
StockIssued1
78072 usd
CY2021Q3 us-gaap Intercompany Agreements Description
IntercompanyAgreementsDescription
On September 1, 2021, we entered into Independent Director Agreements with each of Montel Williams, Leslie G. Bumgarner, Joseph J. Watson, David H. Deming, and Dr. Nicola R. Finley, MD, pursuant to which each director will serve two year terms, with the option to renew terms upon completion, and receive cash compensation in the amount of $1,000 per quarter, paid in equal distributions quarterly, 200,000 shares of common stock issued quarterly in 25,000 share distributions, and a non-qualified stock option to purchase up to 4,000,000 shares of the Company’s common stock at an exercise price of $0.25 per share.
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3154 usd
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
9642 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Reclassification of Prior Year Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p>
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
913 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
12995 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
13908 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
2365 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
2454 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
537 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
138 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
5494 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
8414 usd
CY2022Q4 us-gaap Business Acquisitions Purchase Price Allocation Subsequent Years Remaining Adjustments
BusinessAcquisitionsPurchasePriceAllocationSubsequentYearsRemainingAdjustments
592000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
583586 usd
us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
592000 usd
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
583586 usd
CY2022Q4 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
6986 usd
CY2021Q4 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
17022 usd
CY2022Q4 bfyw Business Acquisitions Net Income Loss
BusinessAcquisitionsNetIncomeLoss
-659935 usd
CY2021Q4 bfyw Business Acquisitions Net Income Loss
BusinessAcquisitionsNetIncomeLoss
-1087775 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
15676 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
52496 usd
bfyw Business Acquisitions Net Income Loss
BusinessAcquisitionsNetIncomeLoss
-2319485 usd
bfyw Business Acquisitions Net Income Loss
BusinessAcquisitionsNetIncomeLoss
-1200616 usd
CY2022Q4 bfyw Revenue
Revenue
1163 usd
bfyw Revenue
Revenue
-51 usd
CY2022Q4 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-657 usd
us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-9757 usd
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
4105379 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
862130 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q3 bfyw Investment Owned Subject To Option Prices
InvestmentOwnedSubjectToOptionPrices
30500000 usd
CY2021Q3 bfyw Execution Term
ExecutionTerm
P36M
CY2021Q3 bfyw Future Securities Agreements
FutureSecuritiesAgreements
15000 usd
CY2021Q3 bfyw Immediately Purchase
ImmediatelyPurchase
250000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021Q3 bfyw Restricted Common Stock Percentage
RestrictedCommonStockPercentage
0.15 pure
CY2021Q3 bfyw Outstanding Shares Common Stock Percentage
OutstandingSharesCommonStockPercentage
0.0499 pure
CY2021Q3 bfyw Exchange Period
ExchangePeriod
P12M
CY2021Q3 us-gaap Officers Compensation
OfficersCompensation
20000 usd
CY2022Q4 bfyw Exchange Period
ExchangePeriod
P12M
CY2022Q4 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1250000 shares
CY2022Q4 us-gaap Officers Compensation
OfficersCompensation
30000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
bfyw Description Of Preferred Stock Shares Issued And Outstanding
DescriptionOfPreferredStockSharesIssuedAndOutstanding
There were 700,000 and 0 shares issued and outstanding as of November 30, 2022 and February 28, 2022, respectively.
CY2022Q2 bfyw Closing Share Price
ClosingSharePrice
6687 usd
us-gaap Significant Purchase Commitment Description
SignificantPurchaseCommitmentDescription
On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the "Note"). The closing of the Purchase Agreements occurred on April 12, 2022. The Note bears an original issue discount of $31,000, and interest of 12% per year and mature on April 12, 2023 (the "Maturity Date"). The Note is convertible into shares of the Company's common stock at conversion price of $0.037 per share, subject to adjustment as provided therein.
bfyw Purchase Commitment Shares
PurchaseCommitmentShares
4960000 shares
CY2022Q3 bfyw Share Based Compensation Arrangement By Share Based Payment Award Options Forfeituresdescription
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresdescription
On July 27, 2022 the Company filed its Pre-14-C notice and accompanying Information Statement and furnished this information to the holders of shares of common stock, par value $0.0001 per share, of Better For You Wellness, Inc., a Nevada corporation (the “Company”), pursuant to Section 78.320 of the Nevada General Corporation Law, Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Regulation 14C and Schedule 14C thereunder, in connection with the approval of the following actions taken by the Company’s Board of Directors (the “Board”) and by written consent of the holders of a majority of the voting power of the issued and outstanding capital stock of the Company, to amend our certificate of incorporation, as amended (the “Certificate”), to increase the number of authorized shares of common stock from 500,000,000 to 1,000,000,000 (the “Authorized Share Increase” or “Corporate Action”). 
CY2022Q3 us-gaap Capital Units Outstanding
CapitalUnitsOutstanding
78.32 shares
CY2022Q3 bfyw Proceeds From Restricted Common Stock
ProceedsFromRestrictedCommonStock
3750 usd
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
2686667 shares
bfyw Extension Value
ExtensionValue
64211 usd
CY2022Q4 bfyw Authorized The Issuance Of Common Shares
AuthorizedTheIssuanceOfCommonShares
760780 shares
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
17500 shares
CY2022Q4 us-gaap Partners Capital
PartnersCapital
17500 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
1250000 shares
CY2022Q4 bfyw Consideration Amount
ConsiderationAmount
30000 usd
CY2022Q4 us-gaap Alternative Investment
AlternativeInvestment
20000000 usd
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
10500000 shares
CY2022Q1 bfyw Stock Option Description
StockOptionDescription
7,000,000 shares vest over the next 2 years.
bfyw Forfeited Shares
ForfeitedShares
2500000 shares
us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.98 pure
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
274025 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
1853540 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
17424 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2021Q4 us-gaap Interest Expense Other
InterestExpenseOther
usd
bfyw Loan Received From Related Party
LoanReceivedFromRelatedParty
39500 usd
CY2022Q4 bfyw Loan Received From Related Party
LoanReceivedFromRelatedParty
145000 usd
CY2022Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
284499 usd
us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.66 pure
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.037
CY2022Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
760870 shares
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.023
CY2022Q4 bfyw Retire Loan Amount
RetireLoanAmount
17500 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
35000 usd
CY2022Q4 us-gaap Related Party Tax Expense Effect Of Change In Allocation Methodology
RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology
17500 usd
us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.66 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
0.037
us-gaap Conversion Of Stock Description
ConversionOfStockDescription
Aprari Solutions will be paid $25,000 over 12 months for accounting services, and for fractional CFO services, $30,000 in cash and $10,000 in stock over 12 months.
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
usd
CY2022Q1 us-gaap Deferred Fuel Cost
DeferredFuelCost
usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2022Q1 us-gaap Goodwill
Goodwill
usd
CY2022Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
usd
CY2022Q1 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
usd
CY2022Q1 bfyw Revenue Payable
RevenuePayable
usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
usd
CY2022Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2022Q1 bfyw Notes Payable Shopifys Capital
NotesPayableShopifysCapital
usd
CY2022Q1 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
usd
CY2022Q4 bfyw Shares Cancelable
SharesCancelable
usd
CY2021Q4 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Interest Expense Other
InterestExpenseOther
usd
CY2022Q4 us-gaap Other Expenses
OtherExpenses
usd
us-gaap Other Expenses
OtherExpenses
usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q4 us-gaap Other Expenses
OtherExpenses
usd
us-gaap Other Expenses
OtherExpenses
usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q2 bfyw Common Shares Issued After Reorganization
CommonSharesIssuedAfterReorganization
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Subordinated Short Term Debt
ProceedsFromSubordinatedShortTermDebt
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
bfyw Common Shares Issued For Notes Payable Extention
CommonSharesIssuedForNotesPayableExtention
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
CY2021Q4 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
CY2022Q4 us-gaap Other Additional Capital
OtherAdditionalCapital
usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001852707

Files In Submission

Name View Source Status
0001213900-23-017302-index-headers.html Edgar Link pending
0001213900-23-017302-index.html Edgar Link pending
0001213900-23-017302.txt Edgar Link pending
0001213900-23-017302-xbrl.zip Edgar Link pending
bfyw-20221130.xsd Edgar Link pending
f10q1122ex31_betterforyou.htm Edgar Link pending
f10q1122ex32_betterforyou.htm Edgar Link pending
f10q1122_betterforyou.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bfyw-20221130_cal.xml Edgar Link unprocessable
bfyw-20221130_def.xml Edgar Link unprocessable
bfyw-20221130_lab.xml Edgar Link unprocessable
bfyw-20221130_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q1122_betterforyou_htm.xml Edgar Link completed